Disc Medicine, Inc.

Disc Medicine, Inc. traded on Nasdaq under the ticker FSDC as a blank-check company sponsored by Foresite Capital, a healthcare-focused investment firm. The SPAC completed its initial public offering in 2020 and targeted opportunities in the life sciences and biotechnology sector, consistent with Foresite Capital's deep focus on healthcare innovation. The company filed a Form 10-Q with the SEC on November 12, 2020, under accession number 0001213900-20-036232, reflecting its reporting obligations as a registered public company during the pre-combination period. As of that filing, FSDC remained in its search phase, evaluating potential business combination targets across the healthcare landscape. Sign up for full data on SpacDesk to access complete filing histories, sponsor profiles, and deal timelines for FSDC and hundreds of other SPACs.